EMA Application withdrawn: Insulin Aspart Injection (insulin aspart) — Masuu Pharma Europe Limited

View source ↗

Summary

The EMA withdrew the application for insulin aspart injection by Masuu Pharma Europe Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)

Snippet

Status: Application withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Masuu Pharma Europe Limited